PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Heine, S. ; Alessandrini, F. ; Grosch, J. ; Graß, C. ; Heldner, A. ; Schnautz, B. ; Buters, J.T.M. ; Slusarenko, B.O. ; Krappmann, D. ; Fallarino, F.* ; Ohnmacht, C. ; Schmidt-Weber, C.B. ; Blank, S.

Activation of the aryl hydrocarbon receptor improves allergen-specific immunotherapy of murine allergic airway inflammation: A novel adjuvant option?

Front. Immunol. 15, 1397072 (2024)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
BACKGROUND: Allergen-specific immunotherapy (AIT) is able to restore immune tolerance to allergens in allergic patients. However, some patients do not or only poorly respond to current treatment protocols. Therefore, there is a need for deeper mechanistic insights and further improvement of treatment strategies. The relevance of the aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor, has been investigated in several inflammatory diseases, including allergic asthma. However, its potential role in AIT still needs to be addressed. METHODS: A murine model of AIT in ovalbumin-induced allergic airway inflammation was performed in AhR-deficient (AhR-/-) and wild-type mice. Furthermore, AIT was combined with the application of the high-affinity AhR agonist 10-chloro-7H-benzimidazo[2,1-a]benzo[de]iso-quinolin-7-one (10-Cl-BBQ) as an adjuvant to investigate the effects of AhR activation on therapeutic outcome. RESULTS: Although AhR-/- mice suffer stronger allergic responses than wild-type mice, experimental AIT is comparably effective in both. Nevertheless, combining AIT with the administration of 10-Cl-BBQ improved therapeutic effects by an AhR-dependent mechanism, resulting in decreased cell counts in the bronchoalveolar fluid, decreased pulmonary Th2 and Th17 cell levels, and lower sIgE levels. CONCLUSION: This study demonstrates that the success of AIT is not dependent on the AhR. However, targeting the AhR during AIT can help to dampen inflammation and improve tolerogenic vaccination. Therefore, AhR ligands might represent promising candidates as immunomodulators to enhance the efficacy of AIT.
Impact Factor
Scopus SNIP
Altmetric
5.700
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords 10-cl-bbq ; Ahr Knockout Mice ; Adjuvant ; Allergen-specific Immunotherapy ; Allergic Airway Inflammation ; Aryl Hydrocarbon Receptor ; Immunomodulation; Cd8(+) T-cells; Drug-metabolism; Dendritic Cells; Differentiation; Biochemistry; Expression; Phenotype; Ligands; Cd4(+); Tcdd
Language english
Publication Year 2024
HGF-reported in Year 2024
ISSN (print) / ISBN 1664-3224
e-ISSN 1664-3224
Journal Frontiers in Immunology
Quellenangaben Volume: 15, Issue: , Pages: 1397072 Article Number: , Supplement: ,
Publisher Frontiers
Publishing Place Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland
Reviewing status Peer reviewed
Institute(s) Institute for Allergy Research (IAF)
Research Unit Signaling and Translation (SAT)
POF-Topic(s) 30202 - Environmental Health
30203 - Molecular Targets and Therapies
Research field(s) Allergy
Enabling and Novel Technologies
PSP Element(s) G-505400-001
G-509800-002
Grants Helmholtz Association, Future Topic "Immunology and Inflammation"
DOI 10.3389/fimmu.2024.1397072
WOS ID 001252564900001
Scopus ID 85196635019
PubMed ID 38915403
Erfassungsdatum 2024-07-23
[➜Report correction]